PNC-27
p53-MDM2 Derived Antineoplastic
Chimeric peptide containing the MDM2-binding domain of p53 fused to a membrane-targeting sequence. Studied for selective induction of necrosis in cancer cells expressing membrane-associated HDM2.
Format
5mg / vial
Purity
>98.4%
Category
Immune
Storage
2–8 °C
Research Price
€169
5mg / vial
RESEARCH USE ONLY
This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.
Complete Your Research with the Pen Kit
Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.
€189
View details →IMPORTANT RESEARCH DISCLAIMER
This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA™ assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.